ity loss by improving patients' quality of life. Savings from increased work productivity might off set comparatively high acquisition costs of biological agents.
nomic analyses have recently gained more interest in the dermatological literature [13] [14] [15] [16] [17] [18] . Guidelines for pharmacoeconomic studies recommend to use the societal perspective, which means that direct and indirect costs of disease need to be considered [19] [20] [21] [22] . Th e direct costs are the cost for the intervention itself, e.g. drugs, physician visits and hospitalization cost. Related direct costs include expenditures on information material and transportation cost. In a recent study the annual direct cost of psoriasis treatment in the USA has been estimated to be about 650 million USD, more than half of which is spent on overthe-counter drugs [16] . Indirect costs are defi ned as opportunity cost of persons unable to work. Th ese costs due to lost productivity include costs of absenteeism and presenteeism [23, 24] . 'Presenteeism' is defi ned as lost productivity because of illness or other medical conditions while on the job [25, 26] . With estimated total costs of 150 billion USD per year in the USA, the total costs of presenteeism exceed those of absenteeism [25] . Although it is crucial to include the costs resulting from productivity loss in pharmacoeconomic evaluations, corresponding data for psoriasis patients have not been assessed yet.
Our aim was to estimate the cost of work productivity loss in patients with psoriasis. We were further interested in the association of productivity loss, health-related quality of life (HRQL) and clinical disease severity.
Methods

Setting and Study Population
Th e presented data were collected in the context of a larger cross-sectional study on the morbidity of psoriasis patients, which was conducted through the Internet between January and May 2005. Patients 18 years or older with self-reported psoriasis who accessed the Internet from the USA were eligible. Th e geographical identifi cation of Internet users was inferred from the corresponding Internet protocol addresses. Recruitment included an advertisement at google.com that appeared on the screen when 'psoriasis' or related search terms were entered. Th e advertisement was 'Johns Hopkins Study. Psoriasis & Quality of Life -30-min questionnaire -get your report back' . Aft er clicking the web-link of the advertisement, participants entered the interactive study Internet page.
Ethical approval from the Offi ce for Research Subjects, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md., was received prior to initiating the study. All participants provided informed consent before starting to answer the study questionnaires.
Assessments
Presenteeism , defi ned as lost productivity while on the job, was assessed using the output demands component of the Work Limitations Questionnaire (WLQ) [27] . Th e WLQ is a self-report instrument with adequate psychometric properties (internal consistency, construct validity, reliability, accuracy) [26] . It measures the on-the-job impact of chronic conditions within the past 2 weeks and has already been applied in various psychiatric and rheumatological conditions [26, [28] [29] [30] [31] . From the four WLQ domains (time, physical, output and mental-interpersonal demands) the output demands domain has the highest relative validity and has been shown to be the best predictor of productivity loss. Th e other WLQ scales each exhibit only half the predictive power of the output demands scale or less [27] . Th e output demands scale includes 5 items (handling the workload, fi nishing work on time, working fast enough, working without making mistakes, doing what one is capable of doing). Items are scored on a 0% (limited none of the time) to 100% (limited all of the time) scale. Th e total output demands score is the average item score. It indicates the percentage of time in the prior 2 weeks the respondent was limited performing output demands [27] .
An advantage of the WLQ is that it has been validated against actual work productivity loss: for every 10% increase in the WLQ output demands scale, actual work productivity declined by approximately 4.5% [32] . Th is allowed us to approximate the economic impact of presenteeism due to psoriasis in the USA in terms of USD by applying the following formula: Th e assumptions made for this estimation are discussed below.
To assess the time lost from work because of absences, participants were asked to indicate how many workdays they had missed fully and partly within the past 4 weeks due to health or medical care and how many workdays they missed due to other reasons. A full workday missed was given the value of 1, a part day one of 0.5 [30] . Th e monetary economic impact of health-related absenteeism of persons with psoriasis in the USA was estimated by: percent workdays missed due to medical reasons ؒ average annual income ؒ prevalence ؒ [US population age 18-65 ؒ (1 -unemployment rate)].
We added the cost of presenteeism and the cost of absenteeism to estimate the total cost of health-related work productivity loss (HRWPL) in patients with psoriasis in the USA.
HRQL was assessed using the Dermatology Life Quality Index (DLQI), a widely used instrument with adequate psychometric properties (e.g. validity, reliability, sensitivity to change) [35] [36] [37] . It consists of 10 questions considering the following domains: symptoms and feelings, daily activities, leisure, work and school, personal relationships, and the eff ects of treatment on daily life.
Th e self-administered Psoriasis Area and Severity Index (SAPASI) is a patient-rated instrument with adequate psychometric properties to assess the objective clinical severity of psoriasis [38] [39] [40] [41] [42] . To be applicable in the Internet setting, the SAPASI was slightly modifi ed (mSAPASI): as in the original version, patients rated the intensity of erythema, induration and scaliness on a 12-cm visual analogue scale (VAS) [40] . For estimation of the involved body surface area (BSA), patients were informed that the area of their palmar hand equals roughly 1% of their BSA. Participants were then asked to estimate the percentage of their body covered with psoriatic plaques. As in the original PASI, the percent BSA involvement was recategorized into a semiquantitative score with 0 indicating no, 1 = 1-9%, 2 = 10-29%, 3 = 30-49%, 4 = 50-69%, 5 = 70-89% and 6 = 90-100% BSA involvement [43] .
Th e mSAPASI was calculated using the formula:
[(VAS erythema + VAS scaliness + VAS induration)/3] ؒ BSA score.
Th e mSAPASI score ranges from 0 to 72 with higher scores indicating higher objective disease severity. Severe psoriasis was defi ned as mSAPASI 1 12, a score between 7 and 12 as moderate psoriasis, and a score of less than 7 as mild psoriasis [44] .
Information on sociodemographic characteristics included age, sex, ethnicity, annual household income, education level and average weekly worktime. Information on specifi c disease characteristics of psoriasis included diagnosis by physician, treatment within the past 14 days, joint involvement and presence/absence of facial lesions, genital lesions, hand involvement and feet involvement within the past 14 days. Participants were also asked to rate their overall health state on a 5-point Likert scale and to indicate if they were temporarily or permanently disabled.
To increase internal validity, participants were also asked to indicate whether they answered all questions honestly and whether they had completed the study questionnaire more than once. Participants indicating they did not answer honestly or were participating more than once were excluded from the analysis. Th e questionnaire was designed in a way that allowed proceeding to the next set of questions only if all previous questions had been answered. Th erefore there were no missing data for our analysis.
Statistical Analysis
Th e 2 test and Fisher's exact test were used to compare sociodemographic characteristics, disease characteristics and comorbidity of study participants by HRWPL (median defi ned as cutoff ) [45] . Spearman correlation coeffi cients were calculated to describe the univariate association of HRWPL, DLQI and mSAPASI. Additionally, univariate and multivariate logistic regression analyses were performed to describe factors associated with HRWPL. Th e fi t of the fi nal multivariate model was assessed by Hosmer-Lemeshow's 2 test [45] . Th e study web page was programmed in PERL 5. Javascript was used for real-time data analysis. Th e data were recorded in an SQL database and transferred to Stata statistical soft ware 8.0 for Windows, which was then used to perform the statistical analysis [46] .
Results
A total of 332 persons between the age of 18 and 65 started answering the questionnaires, 54 (16.3%) of whom were currently unemployed. From the remaining 278 participants, 77 (27.7%) dropped out before answering the WLQ. Th e following results are based on the 201 participants who completed the study.
Th e sample was in the majority female, predominately white, less than 50% had completed a college education and about 78% worked full-time. Almost all participants (96%) had physician-diagnosed psoriasis, which was treated only topically in 59%, systemically in about 19% and not at all in 22% of the study subjects. Th e mean clinical severity in terms of mSAPASI was 9.5 ( 8 8.9) with about half of the patients being categorized as having mild and about 25% as having moderate or severe psoriasis. About 22% of patients reported presence of psoriatic arthritis, 48% lesions on their hands and 32% involvement of their face. Th e mean DLQI was 10.8 ( 8 7.1); three quarters of the participants rated their health status as good, very good or excellent ( table 1 ) .
Presenteeism and Absenteeism
On average, participants had missed 6.6% ( 8 15.4%) of their working time within the past 4 weeks because of health problems. Absences due to reasons other than health accounted for 7.3% ( 8 16.1%) of the working time. 34% of participants had missed at least 1 day of work, and 10% had missed 3 or more days of work within the past 4 weeks due to problems with their health. Assuming generalizability of these results, the annual cost of health-related absenteeism of psoriasis patients in the USA amounts to about USD 7,696,308,000. Th e mean WLQ output demands score was 16.8 ( 8 20.1) refl ecting a mean productivity loss because of presenteeism of 7.6% ( 8 9.1%), and an annual cost of about USD 8,862,415,000. Based on these numbers, the total HRWPL in psoriasis patients was calculated to amount to about USD 16,558,723,000.
Factors Associated with HRWPL
None of the sociodemographic characteristics assessed was signifi cantly associated with HRWPL. Patients with physician-diagnosed psoriasis tended to have a higher HRWPL (p = 0.07). Among patients with a higher HRWPL, 57% reported lesions on their hands compared to 39.6% of the subgroup with a lower HRWPL (p = 0.01). Mild objective disease severity was associated with a lower likelihood of high HRWPL, whereas similar proportions were classifi ed as having severe psoriasis in the high-and low-HRWPL groups (26 vs. 23.8%; table 1 ). Th e correlation between mSAPASI and HRWPL was only weak ( = 0.22). Both psoriatic arthritis and disability were more frequent in the subgroup with a higher HRW-PL, but these associations were not statistically signifi cant. Apart from mean age, mean clinical severity and mean subjective severity, results are expressed as percentages. SD = Standard deviation; -= not applicable, Fisher's exact test performed.
Self-classifi cation of the health status as 'poor' or 'fair' was a positive predictor for a higher HRWPL (p ! 0.01; table 1 ).
A clear dose-response relationship between HRWPL and HRQL impairment was observed (p values for trend ! 0.001 for all strata). More than 50% of the participants in the highest HRWPL tertile had a DLQI of more than 12, whereas more than half of the patients with an HRWPL of less than 2% were also in the lowest DLQI group ( table 1 , fi g. 1 ). Th e correlation between DLQI and HRWPL was also highly statistically signifi cant (p ! 0.001; = 0.47). Table 2 summarizes results from the univariate logistic regression analysis. Compared to the subgroup with low HRQL impairment the odds of a higher HRWPL was 3.32 for patients with moderate and 7.38 for patients with high HRQL impairment (p ! 0.01 for each). Additional statistically signifi cant predictors for a high HRWPL included moderate or severe objective disease severity (odds ratio = 2.11; p = 0.01) and psoriatic lesions on the hands (odds ratio = 2.02; p = 0.01; table 2 ). In the fi nal multi-adjusted logistic regression model predicting HRWPL, only HRQL impairment (DLQI) and temporal/ permanent disability were independently associated with HRWPL ( table 3 ) . Age, gender and annual household income, weekly working time, objective disease severity (mSAPASI) and hand involvement were included in the fi nal model due to results from the univariate analysis and considerations regarding potential confounding. Th e adjusted odds ratio of high HRWPL for participants with a DLQI score of 12 or more compared to those with a lower HRQL impairment (DLQI ! 6) was 7.81 (p ! 0.01; table 3 ). Reference groups are indicated in parentheses. 
Discussion
Not unexpectedly, we found evidence of substantial work productivity loss in patients with psoriasis. Indirect costs due to decreased productivity while on the job and due to health-related absenteeism seem to substantially exceed the direct cost of psoriasis treatment [16] .
Th ere is good reason to believe that intervention can reduce HRWPL primarily by improving the patients' HRQL. Positive impact on HRQL has recently been reported for infl iximab, etanercept, alefacept, efalizumab and cyclosporine [47] [48] [49] [50] [51] [52] . Work productivity has not been included as an outcome in psoriasis studies yet. In patients with rheumatoid arthritis, Yelin et al.
[53] found evidence of improved work productivity and employment status aft er etanercept treatment. Contrary to current guidelines on pharmacoeconomic analyses, published cost-eff ectiveness studies on antipsoriatic agents do not consider indirect cost and can therefore only draw an incomplete picture of effi ciency [19] [20] [21] [22] [54] [55] [56] [57] . Th erefore, it is critically important to consider HRWPL in future effectiveness and cost-eff ectiveness studies on antipsoriatic remedies. It is possible that savings from increased work productivity off set the comparatively high acquisition costs of biologicals. Evidence for a high effi ciency of these agents would fundamentally infl uence the ongoing debate about their appropriate indication and target population.
An advantage of collecting data over the Internet is that participants are more likely to disclose private issues, which may result in data with higher validity compared to other methodologies [58, 59] . In an Internet-recruited sample patients from all diff erent geographical regions within the USA could easily participate. For both the Internet setting and the US healthcare system, signifi cant ethnic and socioeconomic disparities regarding access exist [60] [61] [62] .
As in other Internet-based studies, females and younger age groups appeared to be more likely and ethnic minorities less likely to participate [63] . Additionally, patients with psoriatic arthritis seem to be overrepresented in our sample. Here, misclassifi cation by considering arthrosis or other joint diseases unrelated to psoriasis as psoriatic arthritis might be present. It cannot be excluded that patients who are more frustrated with their psoriasis and who have experienced more disease-related adverse working eff ects than the average psoriasis patient were more likely to take the time to respond to the advertisement and to complete the questionnaire so that recruitment bias cannot be excluded. Th is type of selection bias might have led to an overestimation of adverse working eff ects in patients suff ering from psoriasis. Although recruitment bias is a general problem associated with surveys rather than a specifi c disadvantage of an Internetbased study, our results should be interpreted with caution. To overcome the problem of selection bias in future studies on HRWPL in psoriasis we recommend to draw a suffi ciently large random sample from a source population in a clinical setting. In a survey on disease experiences, it is possible that participants tend to recall healthrelated problems better than experiences unrelated to the condition of interest. Th erefore, an overestimation of the number of missed working time because of psoriasis cannot be ruled out. However, our qualitative fi nding that HRQL unlike clinical severity of psoriasis is related to Table 3 . Multi-adjusted a logistic regression on productivity loss because of diseaserelated absences and presenteeism (productivity loss 67.3% vs. productivity loss <7.3%; n = 201) HRWPL would neither be infl uenced by an overrepresentation of patients with more disease-related work limitations nor by diff erential recall bias with respect to the reason for missed working time.
A possible limitation of our study is the validity of the case defi nition. 96% of the study subjects reported that psoriasis was diagnosed by a physician. In another sample of psoriasis patients, Shikiar et al. [64] observed high construct validity of self-reported data both with respect to each other and to clinical assessments. Participants with lower HRWPL were less likely to have physician-diagnosed psoriasis so that a selection bias would underestimate the true HRWPL of psoriasis patients ( table 1 ) . In order to be applicable for the Internet setting, we used a modifi ed version of the SAPASI with direct estimation of BSA involvement. Th e distribution in our sample of the mSAPASI was 9.5 8 8.9, which is almost identical to the distribution of the SAPASI in its validation study [40] . Both WLQ and DLQI are instruments with adequate psychometric properties but have not been validated in an Internet setting before [26, 37] . Th e observed distribution of the DLQI was highly similar to the distributions observed in other settings [37] . Th e accuracy of self-reported absence days has been established by Revicki et al. [65] . Overall, the quality of the collected data is considered high, particularly with regard to internal validity.
Th e mean WLQ output demands score we observed for psoriasis was similar to other chronic conditions including rheumatoid arthritis, osteoarthritis and dysthymia [28, 29, 31] . Both productivity loss due to health-related absenteeism and to presenteeism was about twice as high in patients with major depression compared to our sample [30] .
Th e reader should not direct his attention primarily on the exact dollar cost of HRWPL in psoriasis patients. Th e message of the presented analysis is rather that the economic impact of HRWPL clearly exceeds the direct treatment-related costs [16] . With the formula we applied the annual costs of presenteeism and absenteeism are only approximations. Th e distributions of both presenteeism and absenteeism were positively skewed, but averages were used in the formula so that the true cost might be underestimated. On the other hand, because health-related rather than psoriasis-related productivity loss was assessed, comorbidity probably accounts for an overestimation of HRWPL solely attributable to psoriasis. Th e calculated cost assumes both generalizability of our productivity loss data and applicability of the average annual income data on the average employed psoriasis patient. Problems with these assumptions could have possibly biased our estimation in both directions. We further assumed that the unemployment rate in our study sample was generalizable to all psoriasis patients in the USA. However, unemployment was about 3 times more likely in our sample than in the US general population (16.3 vs. 5.5%) [66] . Th is fi nding suggests an additional economic burden of psoriasis due to increased unemployment, which is not included in our calculation.
Our fi ndings suggest that HRQL is an independent predictor of HRWPL. Th e weak crude association between HRWPL and clinical disease severity (mSAPASI) is probably confounded by HRQL impairment. Controlling for HRQL even involvement of the hands, one of the most obvious predictors of HRWPL, was only weakly associated with work productivity. Th is highlights that -at least from a societal health-economic perspective -strategies need to primarily focus on the patients' subjective wellbeing rather than on objective clinical signs.
